TY - JOUR
KW - Buprenorphine/therapeutic use
KW - Drug Overdose/epidemiology
KW - Humans
KW - Naloxone/therapeutic use
KW - Narcotic Antagonists/therapeutic use
KW - Opiate Overdose
KW - Opioid-Related Disorders/drug therapy/epidemiology
KW - Pharmacies
KW - Pharmacy
KW - United States/epidemiology
KW - access
KW - buprenorphine
KW - Community pharmacies
KW - opioid-related disorders
AU - N. J. Kazerouni
AU - A. N. Irwin
AU - X. A. Levander
AU - J. Geddes
AU - K. Johnston
AU - C. J. Gostanian
AU - B. S. Mayfield
AU - B. T. Montgomery
AU - D. C. Graalum
AU - D. M. Hartung
A1 - 
AD - College of Pharmacy, Oregon State University/Oregon Health & Science University, Portland, OR, United States.; College of Pharmacy, Oregon State University/Oregon Health & Science University, Portland, OR, United States.; Oregon Health & Science University, Department of Medicine Division of General Internal Medicine Section of Addiction Medicine, 3181 SW Sam Jackson Park Rd., Portland, OR, 97239, United States. Electronic address: levander@ohsu.edu.; College of Pharmacy, Oregon State University/Oregon Health & Science University, Portland, OR, United States.; College of Pharmacy, Oregon State University/Oregon Health & Science University, Portland, OR, United States.; College of Pharmacy, Oregon State University/Oregon Health & Science University, Portland, OR, United States.; College of Pharmacy, Oregon State University/Oregon Health & Science University, Portland, OR, United States.; College of Pharmacy, Oregon State University/Oregon Health & Science University, Portland, OR, United States.; MedSavvy/Cambia Health Solutions, Portland, OR, United States.; College of Pharmacy, Oregon State University/Oregon Health & Science University, Portland, OR, United States. Electronic address: hartungd@ohsu.edu.
BT - Drug and alcohol dependence
C5 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
CY - Ireland
DO - 10.1016/j.drugalcdep.2021.108729
JF - Drug and alcohol dependence
LA - eng
M1 - Journal Article
PB - Elsevier B.V
PP - Ireland
PY - 2021
SN - 1879-0046; 0376-8716
SP - 108729
T1 - Pharmacy-related buprenorphine access barriers: An audit of pharmacies in counties with a high opioid overdose burden
T2 - Drug and alcohol dependence
TI - Pharmacy-related buprenorphine access barriers: An audit of pharmacies in counties with a high opioid overdose burden
U1 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
U2 - 33932744
U3 - 10.1016/j.drugalcdep.2021.108729
VL - 224
VO - 1879-0046; 0376-8716
Y1 - 2021
Y2 - Jul 1
ER -